KROS — Keros Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Annual balance sheet for Keros Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	230	279	331	560	287
Net Total Accounts Receivable
Net Total Receivables	18.2	0	0.143	2.74	5.82
Prepaid Expenses
Total Other Current Assets
Total Current Assets	251	286	347	589	315
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.4	17.6	19.5	23.5	21.1
Other Long Term Assets
Total Assets	255	307	370	616	338
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11.8	16.5	24.4	27.4	20.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	12.1	29.4	37.8	44.3	34.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	243	277	332	572	303
Total Liabilities & Shareholders' Equity	255	307	370	616	338
Total Common Shares Outstanding